Comment on “Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis”
Abstract
No Abstract
1. Bhuvanendran Pillai A, Wong CM, Inche Zainal Abidin ND, et al (2022). Chlamydia infection as a risk factor for cervical cancer: A Systematic Review and Meta-Analysis. Iran J Public Health, 51 (3):508-517.
2. Bashir Y, Conlon KC (2018). Step by step guide to do a systematic review and meta-analysis for medical professionals. Ir J Med Sci,187:447-452.
3. Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemol, 2009;62:1006-12.
4. Shamsi M, Vaziri S, Mozaffari H, Mirzaei M (2020). Systematic review of drug-related hospital admissions: common errors in reporting. Bull Emerg Trauma, 2020; 8:205-206.
2. Bashir Y, Conlon KC (2018). Step by step guide to do a systematic review and meta-analysis for medical professionals. Ir J Med Sci,187:447-452.
3. Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemol, 2009;62:1006-12.
4. Shamsi M, Vaziri S, Mozaffari H, Mirzaei M (2020). Systematic review of drug-related hospital admissions: common errors in reporting. Bull Emerg Trauma, 2020; 8:205-206.
| Files | ||
| Issue | Vol 51 No 6 (2022) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v51i6.9704 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Shamsi M, Mirzaei M. Comment on “Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis”. Iran J Public Health. 2022;51(6):1440-1441.
